The Center for Responsible Science joined a group of clinical trial participants in suing the FDA for denying a June 2014 citizen petition.

Drugmakers submitting anonymous clinical data in applications to the European Medicines Agency must keep up on technology advances that could put that data at risk for re-identification.

The International Committee of Medical Journal Editors is seeking feedback on proposed requirements involving transparency for clinical trials authors as a condition for publication in member journals.